Virobay Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
Virobay General Information
Description
Provider of a cysteine cathepsin platform designed to develop and commercialize novel drugs. The company's platform focuses on addressing significant unmet medical needs for the treatment of neuropathic pain, autoimmune diseases and fibrosis and develop safer and more effective therapies for these diseases, enabling patients to get enzyme treatments that regulate essential processes in cells by cleaving certain proteins.
Contact Information
Website
www.virobayinc.comCorporate Office
- 1360 Willow Road
- Suite 100
- Menlo Park, CA 94025
- United States
Corporate Office
- 1360 Willow Road
- Suite 100
- Menlo Park, CA 94025
- United States
Virobay Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 25-Sep-2018 | Completed | Out of Business | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. IPO | 20-Oct-2014 | Cancelled | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 16-Jul-2014 | $18M | $48M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 18-Aug-2006 | $30M | $30M | Completed | Startup |
Virobay Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Virobay Comparisons
Industry
Financing
Details
Virobay Competitors (49)
One of Virobay’s 49 competitors is Nanoviricides, a Corporation company based in Shelton, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanoviricides | Corporation | Shelton, CT | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| Anavex Life Sciences | Corporation | New York, NY | ||||
| Innovimmune Biotherapeutics | Accelerator/Incubator Backed | New York, NY |
Virobay Patents
Virobay Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014189646-A1 | Processes and intermediates useful for preparing cysteine protease inhibitors | Inactive | 24-May-2013 | ||
| WO-2014153113-A2 | Processes and intermediates for the preparation of 3 amino-n-cyclopropyl-2 hydroxypropionamide derivatives | Inactive | 14-Mar-2013 | ||
| WO-2014153113-A3 | Processes and intermediates for the preparation of 3 amino-n-cyclopropyl-2 hydroxypropionamide derivatives | Inactive | 14-Mar-2013 | ||
| US-20140256698-A1 | Cathepsin inhibitors | Inactive | 11-Mar-2013 | ||
| US-20150191459-A1 | Cathepsin inhibitors | Inactive | 11-Mar-2013 | C07D413/12 |
Virobay Signals
Virobay FAQs
-
When was Virobay founded?
Virobay was founded in 2006.
-
Where is Virobay headquartered?
Virobay is headquartered in Menlo Park, CA.
-
What is the size of Virobay?
Virobay has 6 total employees.
-
What industry is Virobay in?
Virobay’s primary industry is Drug Discovery.
-
Is Virobay a private or public company?
Virobay is a Private company.
-
What is Virobay’s current revenue?
The current revenue for Virobay is .
-
How much funding has Virobay raised over time?
Virobay has raised $48M.
-
Who are Virobay’s competitors?
Nanoviricides, Genentech, Renova Therapeutics, Anavex Life Sciences, and Innovimmune Biotherapeutics are some of the 49 competitors of Virobay.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process